NBVA / NBVAF - Nubeva Technologies - has patented a solution to ransomware. It is an endpoint software - easily and inexpensively deployable - that intercepts and enables fast, inexpensive and complete reversal of ransomware infection. It has been tested extensively and validated by third parties. Sales numbers may ramp exponentially over the next several quarters. The economic and security benefits of their product are significant. It is an SAAS model.
Thinly traded, the stock has previously formed several bases and tested significant breakouts that sputtered from lack of support.
With increased visibility and an expected improvement in company fundamentals, as well as the potential for meaningful news flow, an explosive move to the upside is possible - support levels will rise accordingly.